Get the tools used by (smart)2 investors.
SP500 0.1%DOW 0.3%FTSE 100 -0.1%NIKKEI 0.5%OIL -1.8%GOLD 1.4%
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

EBITDA Forecast (FINBOX) for Indivior PLC

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

INDV: Indivior PLC

Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States...

11.57 USD
Price
– USD
Fair Value
–
Upside
7.33 - 18.59
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Indivior PLC's EBITDA Forecast (FINBOX):

Dec 2026Dec 2028Dec 2030Dec 2032Dec 2034300 M400 M500 M600 M
Performance Summary
  • Indivior's ebitda forecast for the next fiscal year is 268.4 million
  • Indivior's ebitda forecast is expected to average 322.4 million over the next 5 fiscal years.
  • Indivior's is expected to deliver median ebitda forecast of 316.8 million over the next 5 fiscal years.

How does Indivior's EBITDA Forecast (FINBOX) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Indivior PLC because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Indivior EBITDA Forecast (FINBOX) Benchmarks
NameTickerEBITDA Forecast (FINBOX)
Aquestive Therapeutics IncNASDAQGM:AQST-50.3 M
HealthcareSECTOR:HLTH.US-7.153 M
Faes Farma SALSE:0K9H120.5 M
Indivior PLCNASDAQGS:INDV268.4 M
Amneal Pharmaceuticals Inc Class ANASDAQGS:AMRX666.4 M
ALK-ABELLO A/SLSE:0OIR1.866 B
Viatris Inc.LSE:0A5V4.021 B
Teva Pharmaceutical Industries LimitedLSE:0LER4.875 B
Titan Pharmaceuticals IncNASDAQCM:TTNPNA
Eli Lilly and CompanyLSE:0Q1G22.429 B
Pfizer Inc.LSE:0Q1N24.864 B
Merck & Co IncLSE:0QAH30.511 B

Metric Usage: EBITDA Forecast

Hide this widget
ebitda_proj
Slug
number
Datatype
text
Format
current
Default Period
FY, Q
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to EBITDA Forecast (FINBOX) in the forecast category include:

View Full List

Search for metric or datapoint

EBITDA Forecast

Forecasted earnings before interest, taxes, depreciation and amortization (EBITDA).

Definition of EBITDA Forecast (FINBOX)

Hide this widget
Forecasted earnings before interest, taxes, depreciation and amortization (EBITDA).

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-293.5 M1.207 B2.707 B5.283 B0200400600

The chart above depicts the distribution of ebitda forecast (finbox) for companies operating in the Healthcare sector in the Developed economic region. Over 1,630 companies were considered in this analysis, and 1,571 had meaningful values. The average ebitda forecast (finbox) of companies in the sector is 156.4 M with a standard deviation of 609.4 M.

Indivior PLC's EBITDA Forecast (FINBOX) of 268.4 M ranks in the 87.0% percentile for the sector. The following table provides additional summary stats:

EBITDA Forecast (FINBOX) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents1,637
Included Constituents1,571
Min-324.4 M
Max5.217 B
Median3.574 M
Mean156.4 M
Standard Deviation609.4 M

You can find companies with similar ebitda forecast (finbox) using this stock screener.

All rights reserved. Terms Of Use